2nd JPIAMR-ACTION Joint Call 2022

Basic Information

Disrupting drug Resistance Using Innovative Design - This call aims to improve the treatment of bacterial and fungal infections (including co-infection) in humans, animals or plants through the improvement of the efficacy, specificity, delivery, combinations and/or repurposing of drugs and plant protection agents. In particular, the proposals should focus on licenced antimicrobial agents (antibiotics/antifungals) or agents under pre-clinical and/or early clinical development.

Network

JPIAMR-ACTION

Website

https://www.jpiamr.eu/calls/therapeutics-call-2022/

Aim of the joint call

The DRUID Call aims to improve the treatment of bacterial and fungal infections (including co-infection) and/or the prevention of the emergence/spread of resistance in humans, animals or plants through the improvement of the efficacy, specificity, delivery, combinations and/or repurposing of drugs and plant protection agents.

Type of joint call

Two Stages - Call with pre-proposals and full proposals submissions

Events

-                                                Launch date
+/01/2022
-                                                Deadline Pre-Proposal
+/03/2022 Submitted proposal: n/a
-                                                Deadline Full-Proposal
+/07/2022 Submitted proposal: n/a
-                                                Evaluation End Date
+/11/2022
                                                Successful proposal: n/a
                                                Proposals funded: n/a

Is call co-funded?

Call follow up funding

n/a

Call reasons

n/a

Research fields

Biotechnology
Environment
Food, agriculture and fisheries
Health
Industrial production
Nanosciences and nanotechnologies
Socio-economics sciences and humanities

Type of research

n/a

Target groups

Higher Education Institutions (HEIs)
Public Research Organisations (PROs)
Private and Semi-private Research and Technology Organisations (RTOs)
SME (Small and Medium Enterprises)
Large Corporations

Participating networks

n/a

Organisations Participating

Show on map

Country	Organisation
Belgium	National Fund for Scientific Research (FNRS)
Belgium	Research Foundation Flanders (FWO)
Canada	Canadian Institutes of Health Research (CIHR)
Czech Republic	Ministry of Education Youth and Sports (MEYS-MSMT)
Denmark	Innovation Fund Denmark (Innofond)
Estonia	Estonian Science Foundation (ETAG)
France	National Research Agency (ANR)
Germany	Federal Ministry of Education and Research (BMBF)
Hungary	National Research, Development and Innovation Office (NKFIH)
Israel	Ministry of Health (CSO-MOH)
Italy	Ministry of Health (MOH/MDS)
Italy	REGIONAL FOUNDATION FOR BIOMEDICAL RESEARCH (FRRB)
Latvia	State Education Development Agency (VIAA)
Lithuania	Research Council of Lithuania (LSC/LMT/RCL)
Moldova	National Agency for Research and Development (NARD)
Poland	National Centre for Research and Development (NCBiR)
Poland	National Science Centre (NCN)
Spain	Institute of Health Carlos III (ISCIII)
Spain	Spanish State Research Agency (AEI)
Sweden	Swedish Agency for International Development (SIDA)
Sweden	Swedish Governmental Agency for Innovation Systems (VINNOVA)
Sweden	Swedish Research Council (VR/SRC)
Switzerland	Swiss National Science Foundation (SNSF/SNF)
United Kingdom	United Kingdom Research and Innovation (UKRI)

Funded Projects

Acronym	Title	Start	End	No. partners
ACOMa	Optimization of Antibiotic Combinations using Organoids for ...	29/05/2023	28/05/2026	5
APRINHA	New Inhalation Formulations for Improved Delivery of Antimic...	01/01/2023	31/12/2025	7
CAVIFOS	Optimization and implementation of ceftazidime or ceftazidim...	01/05/2023	30/04/2026	6
CycleDrug	Disrupting drug resistance by exploiting collateral sensitiv...	30/12/2022	29/12/2025	6
DONATE	LyophilizeD fecal micrObiome traNsfer for primAry closTridio...	15/02/2023	14/02/2026	7
KLEOPATRA	Design and implementation of effective cOmbination of Phages...	01/06/2023	31/05/2026	7
MURYXIN	The disulfide bond as a chemical tool in cyclic peptide anti...	26/06/2023	25/06/2026	7
NOBACT	Identification of a Novel non-antibiotic Bactericidal agent ...	01/03/2023	28/02/2026	5
StopStaphGrowth	Optimisation of bi-therapy inhibition of Staphylococcus aure...	01/04/2023	31/03/2026	5
SulTAn	Optimized dosing regimens for the combinations of sulfonamid...	01/02/2023	31/01/2026	6
TANDEM	Targeted Nitroxoline Delivery for Treatment of Multidrug-res...	01/06/2023	31/05/2026	4
TRA-COAT	Development and in vivo validation of a novel triggered rele...	01/06/2023	31/05/2026	3
VARIANT	Design and implementation of silver-based nanoparticles for ...	01/04/2023	31/03/2026	4